食品伙伴網(wǎng)訊   據(jù)歐盟食品安全局（EFSA）消息，2018年7月23日，歐盟就蛋膜水解產(chǎn)物（egg membrane hydrolysate）作為新型食品的安全性發(fā)布意見(jiàn)。

 

    應(yīng)歐盟委員會(huì)的要求，歐盟膳食、營(yíng)養(yǎng)和過(guò)敏癥科學(xué)小組（NDA）按照 法規(guī)（EU）2015/2283提供關(guān)于蛋膜水解產(chǎn)物作為新型食品安全性的科學(xué)意見(jiàn)。蛋膜水解產(chǎn)物是一種水溶性的卵膜水解物，是通過(guò)對(duì)蛋殼薄層進(jìn)行堿性處理而得到的。它的主要成分是彈性蛋白、膠原蛋白和糖胺聚糖。經(jīng)過(guò)評(píng)估，專家小組得出結(jié)論，蛋膜水解產(chǎn)物作為新型食品在擬議的使用限量下是安全的，劑量為450mg/天，目標(biāo)人群是普通成年人。

 

    部分原文報(bào)道如下：

 

    Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies （NDA） was asked to deliver a scientific opinion on egg membrane hydrolysate as a novel food （NF） pursuant to Regulation （EU） 2015/2283. The NF is a water‐soluble hydrolysate of egg membrane, produced by alkaline treatment of the thin layer lining the shells of chicken eggs. The main constituents of the NF are elastin, collagen and glycosaminoglycans. The information provided on the production process, batch‐to‐batch variability, composition and specifications of the NF is sufficient and does not raise safety concerns. The NF is proposed to be used as a food supplement for adults, at a maximum daily amount of 450 mg. The consumption of the NF is not nutritionally disadvantageous. One human study, which was not designed for safety but included a number of endpoints pertaining to safety, did not raise safety concerns. The Panel considers that taking into account the information provided and considering the nature, the source and the production process of the NF, there are no safety concerns for the NF at the proposed conditions of use. The Panel concludes that the NF, egg membrane hydrolysate, is safe as a food supplement at a dose of 450 mg/day. The target population for the NF is the general adult population.